Recombinant Human SLC12A7 Protein (HEK293)，His & Flag

SLC12A7, a member of the SLC12 family of solute carriers, encodes a sodium-potassium-chloride co-transporter primarily expressed in various tissues, including the brain and kidney. This protein plays a crucial role in maintaining cellular ion balance and homeostasis, influencing processes like cell volume regulation and neurotransmitter release. Abnormal functioning of SLC12A7 has been implicated in a range of physiological disorders, including hypertension and neurological diseases. Recent studies have highlighted its potential as a therapeutic target, prompting researchers to investigate the structure and function of SLC12A7 through recombinant protein production. By utilizing techniques such as gene cloning and protein expression systems, scientists aim to generate and purify functional SLC12A7 protein for detailed biochemical characterization. This research not only enhances our understanding of the physiological roles of SLC12A7 but also paves the way for the development of novel interventions that could modulate its activity in disease contexts. The successful production of recombinant SLC12A7 would facilitate high-throughput screening for potential modulators, thus contributing to drug discovery efforts targeting ion transport mechanisms. Overall, the study of SLC12A7 at the molecular level is pivotal in elucidating its contributions to cellular physiology and its potential role in disease management.